In one study, 10.0% of cases of B-lymphoblastic leukemia/lymphoma expressed one or more T cell antigens: CD4 in 5.0% of cases, CD5 in 2.2% of cases, CD7 in 2.2% of cases, and CD2 in 0.6% of cases [7]. This evidence concerns the gene CD7 and lymphoma.